ORTEXORTEX News
Tracking CRCL? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CR
Trader NoteCRCL

Circle Shorts Ease While Options Turn Defensive Before November Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 22:50

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

CRCL is a stablecoin infrastructure company trading at $85.87, up 5.5% on Tuesday and roughly 2% on the week, an unusually resilient showing against a peer group that has shed a median of 10% over the same period.

Short positioning has pulled back from its recent peak, but the level remains historically elevated. Short interest slipped to 12.4% of the free float on Tuesday, down from 12.9% a week ago, after reaching a local high around 28.2 million shares in mid-October. The decline is modest. Over the past month, the short count has still grown by nearly 47%, building steadily from around 18 to 19 million shares in mid-September. The ORTEX short score has eased from 62.1 at its October peak to 59.7, but that still puts it in the upper half of its recent range. The borrow market remains loose enough to keep this in the category of deliberate positioning rather than forced covering. Availability is now at 268%, meaning roughly 92 million shares remain available to lend against roughly 27 million already borrowed. Cost to borrow has barely moved, at under 0.5%. Nothing in the lending market is tightening to a degree that would pressure existing shorts.

What has shifted this week is options positioning. The put/call ratio reached 0.81 on Tuesday, running 2.4 standard deviations above its 20-day average of 0.78. That is the most defensive options reading in the 30-day window, and it has pushed up sharply over the past two sessions even as the stock itself gained ground. The divergence is the interesting tension: price is recovering while downside hedging is increasing. The PCR has room to go further, the 52-week high is 0.96, but the move off a sustained baseline near 0.77 is notable in the two weeks before the November 4 earnings date.

The Street remains divided, and the gap between bulls and bears is wide. Needham raised its target to $134 on Wednesday, the most recent action, reiterating its Buy rating. TD Cowen and others carrying Buy ratings have been lifting targets through September and October. On the other side, Morgan Stanley holds an Underweight with a $37 target, and Wolfe Research maintains an Underperform even after raising its target to $65 from $50. The consensus mean sits at $107, implying a 25% return from current levels, but that average masks a wide distribution. The bull case centres on USDC circulation growth of 72% year-over-year to $75.3 billion and rising transaction volume share. The bear case is built around interest rate sensitivity: Circle's reserve yield revenue falls directly when rates drop, and the Circle Payments Network has yet to demonstrate the adoption needed to offset that pressure. At a price-to-earnings multiple of 61 and EV/EBITDA near 25, the valuation leaves little room for a miss. The EPS momentum factor score of 9 out of 100 ranks near the bottom of the universe, a signal that forward estimates have been coming down.

Institutional flows since the IPO earlier this year show a pattern of early venture holders trimming and mainstream asset managers adding. General Catalyst has exited its position entirely, according to its February 2026 13G/A filing, and James Breyer's stake has been cut from 6.4% to 3.2% over the same period. Against that, BlackRock added 3.3 million shares through September 30, ARK Investment Management added 1.6 million, and the two Vanguard entities have each been building. All insider sales on record are under pre-arranged 10b5-1 plans, including small tranches from CEO Jeremy Allaire in early October, limiting the signal value of those transactions. Retail attention has picked up: the ORTEX alt data layer reports a Wikipedia and ORTEX page-view z-score of 2.2 against the stock's own 90-day history, reflecting above-average engagement this week.

The November 4 date is now 14 days away, and the question the data raises is whether the defensive options positioning and the still-elevated short interest reflect genuine concern about rate sensitivity in the coming print, or simply a re-rating of a high-multiple fintech into an earnings window. The earnings history is worth noting: the last two prints produced one-day moves of 6.7% and 16.6% higher, with five-day gains of 12% to 25%. That asymmetric history may itself be drawing in put buyers as a hedge against a more mixed outcome this time.

Stocks in this article

See the live data behind this article on ORTEX.

Open CRCL on ORTEX →

How this article was generated

Generated
21 Oct 2026, 22:51
Data as of
21 Oct 2026, 22:50
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.